Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

Myelofibrosis

FLAG chemotherapy followed by allogeneic stem cell transplant using nonmyeloablative conditioning induces regression of myelofibrosis with myeloid metaplasia

Summary:

A 38-year-old woman with agnogenic myeloid metaplasia complicated by the poor prognostic factors of severe osteosclerosis, prominent hepatosplenomegaly, and profound anemia was treated with FLAG chemotherapy to decrease her organomegaly before undergoing a nonmyeloablative allogeneic stem cell transplant from a matched-sibling donor. The patient's pre- and post transplant course were complicated by an autoimmune disorder and her post transplant course was complicated by severe hepatic and gastrointestinal GVHD. A technetium-99m sulfur colloid scan 4 months post transplant and bone marrow studies 8 months post transplant demonstrated intramedullary hematopoiesis, complete resolution of marrow fibrosis, and partial resolution of osteosclerosis.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3

Similar content being viewed by others

References

  1. Tefferi A . Myelofibrosis with myeloid metaplasia. N Engl J Med 2000; 342: 1255–1265.

    Article  CAS  Google Scholar 

  2. Smith BD, Moliterno A . Biology and management of idiopathic myelofibrosis. Curr Opin Oncol 2001; 13: 91–94.

    Article  CAS  Google Scholar 

  3. Anderson JE, Tefferi A, Craig F et al. Myeloablation and autologous peripheral blood stem cell rescue results in hematologic and clinical responses in patients with myeloid metaplasia with myelofibrosis. Blood 2001; 98: 586–593.

    Article  CAS  Google Scholar 

  4. Guardiola P, Anderson JE, Bandini G et al. Allogeneic stem cell transplantation for agnogenic myeloid metaplasia: a European group for blood and marrow transplantation, Societe Francaise de Greffe de Moelle, Gruppo Italiano per il Trapianto del Modello Osseo, and Fred Hutchinson Cancer Research Center Collaborative Study. Blood 1999; 93: 2831–2838.

    CAS  PubMed  Google Scholar 

  5. Ramakrishna R, Kyle PW, Day PJ, Manoharan A . Evans' syndrome, myelofibrosis, and systemic lupus erythematosus: role of procollagens in myelofibrosis. Pathology 1995; 27: 255–259.

    Article  CAS  Google Scholar 

  6. Paquette R, Meshkinpour A, Rosen P . Autoimmune myelofibrosis: a steroid-responsive cause of bone marrow fibrosis associated with systemic lupus erythematosus. Medicine 1994; 73: 145–152.

    Article  CAS  Google Scholar 

  7. Maris M . Nonmyeloablative allogeneic hematopoietic stem cell transplantation. Fellow Reporter 2001; 6: 59–62.

    Google Scholar 

  8. Cervantes F, Barosi G, Demory JL et al. Myelofibrosis with myeloid metaplasia in young individuals: disease characteristics, prognostic factors, and identification of risk groups. Br J Haematol 1998; 102: 684–690.

    Article  CAS  Google Scholar 

  9. Slavin S, Nagler A, Naparstek E et al. Nonmyeloablative stem cell transplantation and cell therapy as an alternative to conventional bone marrow transplantation with lethal cytoreduction for the treatment of malignant and nonmalignant hematologic diseases. Blood 1998; 91: 756–763.

    CAS  Google Scholar 

  10. Tefferi A, Messa RA, Nagorney DM et al. Splenectomy in myelofibrosis with myeloid metaplasia: a single-institution experience with 223 patients. Blood 2000; 95: 2226–2233.

    CAS  PubMed  Google Scholar 

  11. Li Z, Deeg HJ . Pros and cons of splenectomy in patients with myelofibrosis undergoing stem cell transplantation. Leukemia 2001; 15: 465–467.

    Article  CAS  Google Scholar 

  12. Coates GG, Eisenberg B, Dail DH . Tc-99m sulfur colloid demonstration of diffuse pulmonary interstitial extra medullary hematopoiesis in a patient with myelofibrosis: a case report and review of the literature. Clin Nucl Med 1994; 19: 1079–1084.

    Article  CAS  Google Scholar 

  13. Kucuk O, Gordon LI, Kies MS et al. Estimation of hematopoietic potential by CFU-c and bone marrow scan in cancer patients. Exp Hematol 1984; 12: 101–106.

    CAS  PubMed  Google Scholar 

  14. Derin H, Yetkin E, Ozkilic H et al. Detection of splenosis by radionuclide scanning. Br J Radiol 1987; 60: 873–875.

    Article  CAS  Google Scholar 

  15. Dumarey N, Martin P, Jayankura M et al. A ‘made in one piece’ skeleton in a 22-year-old man suffering from sickle cell anaemia. Clin Rheumatol 2000; 19: 287–290.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to E Carrier.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Tanner, M., Hoh, C., Bashey, A. et al. FLAG chemotherapy followed by allogeneic stem cell transplant using nonmyeloablative conditioning induces regression of myelofibrosis with myeloid metaplasia. Bone Marrow Transplant 32, 581–585 (2003). https://doi.org/10.1038/sj.bmt.1704172

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.bmt.1704172

Keywords

This article is cited by

Search

Quick links